Lensar (LNSR) Total Non-Current Liabilities (2019 - 2026)

Lensar's (LNSR) quarterly Total Non-Current Liabilities came in at $40.8 million in Q1 2026, down 49.4% year-on-year from $80.7 million in Q1 2025, and down 50.66% on a QoQ basis from $82.8 million in Q4 2025.

Lensar (LNSR) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Total Non-Current Liabilities data on file, last reported at $40.8 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 49.4% year-over-year to $40.8 million in Q1 2026; TTM through Mar 2026 was $40.8 million, a 49.4% decrease from a year earlier, with the FY2025 full-year figure at $82.8 million, up 365.05% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $40.8 million, down from $82.8 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for LNSR reached as high as $82.8 million in Q4 2025 and fell as low as $10.4 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $30.2 million across 5 years, with a median of $20.0 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities jumped 516.69% in 2025 and tumbled 49.4% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $13.7 million in 2022, then gained by 1.89% to $14.0 million in 2023, then advanced by 27.54% to $17.8 million in 2024, then surged by 365.05% to $82.8 million in 2025, then slumped by 50.66% to $40.8 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $40.8 million in Q1 2026, $82.8 million in Q4 2025, and $81.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Lensar 70.05 Mn 72.73 Mn 6.38 Mn 40.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.83 Mn
Dec 31, 2025 82.76 Mn
Sep 30, 2025 81.42 Mn
Jun 30, 2025 32.44 Mn
Mar 31, 2025 80.70 Mn
Dec 31, 2024 17.80 Mn
Sep 30, 2024 13.20 Mn
Jun 30, 2024 23.72 Mn
Mar 31, 2024 20.02 Mn
Dec 31, 2023 13.95 Mn
Sep 30, 2023 20.16 Mn
Jun 30, 2023 24.19 Mn
Mar 31, 2023 12.52 Mn
Dec 31, 2022 13.69 Mn
Sep 30, 2022 12.22 Mn
Jun 30, 2022 13.80 Mn
Mar 31, 2022 10.44 Mn
Dec 31, 2021 11.52 Mn
Sep 30, 2021 10.97 Mn
Jun 30, 2021 10.78 Mn